We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

University Hospitals Seidman Cancer Center Provides Comprehensive Care for Women with Ovarian Cancer

If you have been diagnosed with ovarian cancer and are feeling overwhelmed, we understand. Each year, about 22,000 women in the U.S. receive an ovarian cancer diagnosis. While most of these women are over the age of 60, ovarian cancer is found in younger women, too. UH Seidman Cancer Center’s physicians and cancer care specialists are experts at diagnosing and treating ovarian cancer. We know there is hope. If ovarian cancer is diagnosed in the early stages, the chances for successful treatment are high.


Nationally Recognized Cancer Program

UH Seidman Cancer Center is part of the National Cancer Institute-designated Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine, which is one of an elite group of 41 comprehensive cancer hospitals nationwide. We are a nationally recognized cancer center with expertise in both routine and complex care for every stage of ovarian cancer. As an academic medical center, UH Seidman Cancer Center offers leading treatments earlier than most other cancer centers.


Highly Skilled Cancer Care Team

Physicians at the UH Seidman Cancer Center believe that cancer treatment should be customized to fit the individual. We offer patients a multidisciplinary team approach; this means all our cancer doctors, nurses and support staff coordinate your care. Our expert multidisciplinary team works together to offer patients a personalized treatment plan. Skilled professionals on the multidisciplinary team include:

  • Genetic counselors
  • Medical geneticists
  • Medical oncologists
  • Nurse navigators
  • Nurse practitioners
  • Pathologists
  • Plastic and reconstructive surgeons
  • Radiation oncologists
  • Radiologists
  • Social workers
  • Surgical gynecologists
  • Surgical oncologists

Cancer Clinical Trials

UH Seidman Cancer Center has many available clinical trials for patients with ovarian cancer, including:

  • Studying a cancer drug or chemo for women’s GYN cancers. Learn more.
  • Studying the best dose and side effects of a cancer drug given with two chemo drugs for Solid Tumors that have spread or cannot be removed by surgery in patients with liver or kidney problems. Learn more.

Cytoreductive Surgery (CRS) With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at UH Seidman Cancer Center

Sometimes ovarian cancer and certain other abdominal or pelvic cancers can spread to the peritoneum – the membrane that lines the abdomen cavity. When this occurs, the condition is known by such names as peritoneal disease, peritoneal cancer, peritoneal malignancy and peritoneal carcinomatosis.

Many patients with peritoneal cancer benefit considerably from cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). CRS is the surgical removal of the cancerous tumor or tumors from the abdomen or pelvis. HIPEC is a type of chemotherapy in which a heated solution containing an anti-cancer drug is delivered directly into the abdominal cavity following CRS to destroy any leftover cancer cells.

A high-volume location for CRS HIPEC treatment, UH Seidman Cancer Center is one of a few select cancer centers in the country to offer this groundbreaking, life-extending therapy.

Learn More